Outcomes after first percutaneous coronary intervention for acute myocardial infarction according to patient funding

Pamela J Bradshaw1, Shauna Trafalski, Joseph Hung

  • 1School of Population Health, The University of Western Australia, 35 Stirling Highway, Perth, WA, Australia. pamela.bradshaw@uwa.edu.au.

BMC Health Services Research
|September 19, 2014
PubMed

Insights

Private patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) had more procedures but lower mortality. Further research is needed to understand factors influencing these outcomes.

Area of Science:

  • Cardiology
  • Health Services Research
  • Public Health

Background:

  • Disparities in invasive coronary revascularisation for acute myocardial infarction (AMI) exist.
  • Socio-economic factors, income, and funding influence invasive procedure use and patient care.
  • This study compares outcomes for publicly and privately funded patients after first-ever percutaneous coronary intervention (PCI) for AMI.

Purpose of the Study:

  • To determine if one- and five-year outcomes differ for public versus private patients after AMI treated with first-ever PCI.
  • To investigate associations between funding source and subsequent revascularisation procedures and mortality.

Main Methods:

  • Retrospective, population-based cohort study.
  • Linked data analysis of 30-day AMI survivors treated with PCI (1995-2008) in Western Australia.
  • Outcome measures included repeat PCI, recurrent AMI (re-AMI), and all-cause/cardiac mortality at 1 and 5 years.

Main Results:

  • Private patients had a higher adjusted risk for repeat PCI (HR 1.62) and additional revascularisation (HR 1.33) within five years.
  • Private patients showed a lower adjusted risk for all-cause mortality at five years (HR 0.69).
  • Trends suggested reduced risk for cardiac death and re-AMI in private patients.

Conclusions:

  • Private funding for first PCI in AMI is linked to increased likelihood of further revascularisation procedures.
  • Private patients experienced reduced all-cause mortality risk at five years post-PCI.
  • Lifestyle and healthcare factors may explain better survival trends in private patients, though direct links to additional procedures were unclear.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
514
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
492
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
649